Related Experiment Videos
[TNM classification of brain tumor]
1Dept. of Neurological Surgery, National Cancer Center Hospital, Tokyo, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 9, 1998
Summary
The Union for International Cancer Control (UICC) tumor, node, metastasis (TM) staging for astrocytic tumors requires refinement. Survival data indicate that stage IV cases should be analyzed separately by histological subtype for accurate prognosis.
Area of Science:
- Neuro-oncology
- Cancer Staging
- Tumor Biology
Context:
- The Union for International Cancer Control (UICC) tumor, node, metastasis (TM) staging system is widely used for cancer classification.
- Accurate staging is crucial for predicting patient outcomes and guiding treatment strategies.
- Astrocytic tumors of the supratentorial region represent a significant group of primary brain tumors.
Purpose:
- To evaluate the efficacy of the current UICC TM staging system for astrocytic tumors.
- To investigate the prognostic value of tumor size (T classification) within different astrocytic tumor histologies.
- To determine if stage IV astrocytic tumors can be reliably grouped together for survival analysis.
Summary:
- A staging trial was conducted using data from astrocytic tumor cases in the supratentorial region (1978-1987).
- Survival curves were analyzed based on T classification within distinct histological groups (astrocytoma, malignant astrocytoma, glioblastoma).
- Significant survival differences were observed within the T4 group across different histologies, suggesting limitations in current staging.
Impact:
- The study highlights the need for histology-specific T classification within the UICC TM staging system for astrocytic tumors.
- Findings suggest that stage IV astrocytic tumors should not be analyzed as a single entity but stratified by histological subtype.
- This research can inform revisions to cancer staging guidelines, improving prognostic accuracy for brain tumor patients.